The effects of platelet activating factor antagonist, TCV309, on the relationship between electrophysiological and mechanical status during myocardial ischemia and reperfusion.
Second Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
K
K
Tamura
Y
Y
Kimura
T
T
Tamura
S
S
Kitashiro
T
T
Izuoka
T
T
Iwasaka
M
M
Inada
D000200:Action Potentials; D000818:Animals; D004285:Dogs; D004594:Electrophysiology; D006439:Hemodynamics / Q000187:drug effects; D007546:Isoquinolines / Q000494:pharmacology*; D009200:Myocardial Contraction / Q000187:drug effects; D017202:Myocardial Ischemia / Q000503:physiopathology*; D015428:Myocardial Reperfusion Injury / Q000503:physiopathology*; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D011726:Pyridinium Compounds / Q000494:pharmacology*; D044005:Tetrahydroisoquinolines
D007546:Isoquinolines; D010972:Platelet Activating Factor; D011726:Pyridinium Compounds; D044005:Tetrahydroisoquinolines; C067430:TCV 309